Figures computed from official regulatory filings — methodology.
Statistical track record
FreeWin rates and median returns are available with a free account (5 insiders/month).
Create a free accountThis page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
| Company | Type | Value · USD | |
|---|---|---|---|
| Other | $956.4K | SEC | |
| ExerciseD | $211.8K | SEC | |
| ExerciseD | $81.7K | SEC | |
| Exercise | $0 | SEC | |
| Buy | $301.9K | SEC | |
| Buy | $250 | SEC | |
| Buy | $99 | SEC | |
| Buy | $247.5 | SEC | |
| Buy | $100 | SEC | |
| Buy | $250 | SEC | |
| Buy | $100 | SEC | |
| Buy | $1 | SEC | |
| Buy | $250 | SEC | |
| Buy | $247.5 | SEC | |
| Buy | $100 | SEC | |
| ExerciseD | $258.5K | SEC | |
| Buy | $425 | SEC | |
| Buy | $688 | SEC | |
| Buy | $227.5 | SEC | |
| Buy | $724.2 | SEC | |
| Buy | $210.8 | SEC | |
| Buy | $230 | SEC | |
| Buy | $420 | SEC | |
| Buy | $4.1 | SEC | |
| Buy | $230 | SEC |